High Magnitude of Fecal Carriage of Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae at Debre Berhan Comprehensive Specialized Hospital, Ethiopia

References

• Nordmann P, Dortet L, Poirel L. Carbapenem resistance in Enterobacteriaceae: here is the storm! Trends Mol Med. 2012;18(5):263–272. doi:10.1016/j.molmed.2012.03.003
   PubMed Web of Science ®Google Scholar
• Andrew B, Kagirita A, Bazira J. Prevalence of extended-spectrum beta-lactamases-producing microorganisms in patients admitted at KRRH, Southwestern Uganda. Int J Microbiol. 2017;2017:1–5. doi:10.1155/2017/3183076
   Web of Science ®Google Scholar
• Mohamudha PR, Harish B, Parija S. AmpC beta lactamases among Gram negative clinical isolates from a tertiary hospital, South India. Braz J Microbiol. 2010;41(3):596–602. doi:10.1590/S1517-83822010000300009
   Web of Science ®Google Scholar
• Mulki SS, Ramamurthy K, Bhat S. Fecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae in intensive care unit patients. Indian J Crit Care Med. 2017;21(8):525–527. doi:10.4103/ijccm.IJCCM_112_17
   Web of Science ®Google Scholar
• Ruh E, Zakka J, Hoti K, et al. Extended-spectrum β-lactamase, plasmid-mediated AmpC β-lactamase, fluoroquinolone resistance, and decreased susceptibility to carbapenems in Enterobacteriaceae: fecal carriage rates and associated risk factors in the community of Northern Cyprus. Antimicrob Resist Infect Cont. 2019;8(1):1–10.
   Web of Science ®Google Scholar
• Mahamat OO, Tidjani A, Lounnas M, et al. Fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in hospital and community settings in Chad. Antimicrob Resist Infect Control. 2019;8(1):1–7. doi:10.1186/s13756-018-0426-x
   Web of Science ®Google Scholar
• Cantón R, Coque TM. The CTX-M beta-lactamase pandemic. Curr Opin Micrbiol. 2006;9(5):466–475.
   PubMed Web of Science ®Google Scholar
• Rolain J-M. Food and human gut as reservoirs of transferable antibiotic resistance encoding genes. Front Microbiol. 2013;4:1–10. doi:10.3389/fmicb.2013.00173
   Web of Science ®Google Scholar
• Lynch III JP, Clark NM, Zhanel GG. Evolution of antimicrobial resistance among Enterobacteriaceae (focus on extended spectrum β-lactamases and carbapenemases). Expert Opin Pharmacother. 2013;14(2):199–210. doi:10.1517/14656566.2013.763030
   Web of Science ®Google Scholar
• Friedman ND, Carmeli Y, Walton AL, Schwaber MJ. Carbapenem-resistant Enterobacteriaceae: a strategic roadmap for infection control. Infect Control Hosp Epidemiol. 2017;38(5):580–594. doi:10.1017/ice.2017.42
   Web of Science ®Google Scholar
• Islam S, Selvarangan R, Kanwar N, et al. Intestinal carriage of third-generation cephalosporin-resistant and extended-spectrum β-lactamase-producing Enterobacteriaceae in healthy US children. J Pediatr Infect Dis Soc. 2017;7(3):234–240. doi:10.1093/jpids/pix045
   Web of Science ®Google Scholar
• Pilmis B, Cattoir V, Lecointe D, et al. Carriage of ESBL-producing Enterobacteriaceae in French hospitals: the PORTABLSE study. J Hosp Infec. 2018;98(3):247–252. doi:10.1016/j.jhin.2017.11.022
   PubMed Web of Science ®Google Scholar
• Sonda T, Kumburu H, van Zwetselaar M, et al. Meta-analysis of proportion estimates of extended-spectrum-beta-lactamase-producing Enterobacteriaceae in East Africa hospitals. Antimicrob Resist Infect Control. 2016;5(1):1–9. doi:10.1186/s13756-016-0117-4
   PubMed Web of Science ®Google Scholar
• Vialle‐Valentin C, Lecates R, Zhang F, Desta A, Ross‐Degnan D. Predictors of antibiotic use in African communities: evidence from medicines household surveys in five countries. Trop Med Int Health. 2012;17(2):211–222. doi:10.1111/j.1365-3156.2011.02895.x
   Web of Science ®Google Scholar
• Abayneh M, Worku T. Prevalence of multidrug-resistant and extended-spectrum beta-lactamase (ESBL)-producing gram-negative bacilli: a meta-analysis report in Ethiopia. Drug Target Insights. 2020;14(1):16. doi:10.33393/dti.2020.2170
   Web of Science ®Google Scholar
• Aklilu A, Manilal A, Ameya G, Woldemariam M, Siraj M. Gastrointestinal tract colonization rate of extended-spectrum beta-lactamase-and carbapenemase-producing Enterobacteriaceae and associated factors among hospitalized patients in Arba Minch General Hospital, Arba Minch, Ethiopia. Infect Drug Resist. 2020;13:1517. doi:10.2147/IDR.S239092
   PubMed Web of Science ®Google Scholar
• Desta K, Woldeamanuel Y, Azazh A, et al. High gastrointestinal colonization rate with extended-spectrum β-lactamase-producing Enterobacteriaceae in hospitalized patients: emergence of carbapenemase-producing K. pneumoniae in Ethiopia. PLoS One. 2016;11(8):e0161685. doi:10.1371/journal.pone.0161685
   PubMed Web of Science ®Google Scholar
• CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 29th ed. CLSI supplement M100S. Wayne, PA: Clinical and Laboratory Standards Institute; 2019.
   Google Scholar
• Magiorakos A-P, Srinivasan A, Carey R, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281. doi:10.1111/j.1469-0691.2011.03570.x
   PubMed Web of Science ®Google Scholar
• Shenkute D. Fecal carriage of extended-spectrum beta-lactamase and carbapenemase-producing Enterobacteriaceae among hospitalized patients at Debre Berhan Comprehensive Specialized Hospital, North Shoa, Amhara Regional State, Ethiopia [Master’s thesis]. AAU Institute Repository; 2021. Available from:. http://etd.aau.edu.et/handle/123456789/28256. Accessed May 2, 2022.
   Google Scholar
• Abdallah H, Alnaiemi N, Reuland E, et al. Fecal carriage of extended-spectrum β-lactamase-and carbapenemase-producing Enterobacteriaceae in Egyptian patients with community-onset gastrointestinal complaints: a hospital-based cross-sectional study. Antimicrob Resist Infect Control. 2017;6(1):1–7. doi:10.1186/s13756-017-0219-7
   Web of Science ®Google Scholar
• Kibwana UO, Majigo M, Kamori D, Manyahi J. High fecal carriage of extended Beta Lactamase producing Enterobacteriaceae among adult patients admitted in referral hospitals in Dar Es Salaam, Tanzania. BMC Infect Dis. 2020;20(1):1–7. doi:10.1186/s12879-020-05272-4
   Web of Science ®Google Scholar
• Bayleyegn B, Fisaha R, Kasew D. Fecal carriage of extended spectrum beta-lactamase producing Enterobacteriaceae among HIV infected children at the University of Gondar comprehensive specialized hospital Gondar, Ethiopia. AIDS Res Ther. 2021;18(1):1–9. doi:10.1186/s12981-021-00347-x
   Web of Science ®Google Scholar
• Hazirolan G, Mumcuoglu I, Altan G, Ozmen BB, Aksu N, Karahan ZC. Fecal carriage of extended-spectrum beta-lactamase and ampc beta-lactamase-producing Enterobacteriaceae in a Turkish community. Niger J Clin Pract. 2018;21(1):81–86. doi:10.4103/njcp.njcp_79_17
   Web of Science ®Google Scholar
• Arhoune B, Oumokhtar B, Hmami F, et al. Rectal carriage of extended-spectrum beta-lactamase- and carbapenemase-producing Enterobacteriaceae among hospitalised neonates in a neonatal intensive care unit in Fez, Morocco. J Glob Antimicrob Resist. 2017;8:90–96. doi:10.1016/j.jgar.2016.11.004
   Web of Science ®Google Scholar
• Tellevik MG, Blomberg B, Kommedal Ø, Maselle SY, Langeland N, Moyo SJ. High prevalence of faecal carriage of ESBL-producing Enterobacteriaceae among children in Dar Es Salaam, Tanzania. PLoS One. 2016;11(12):1–13.
   Web of Science ®Google Scholar
• Girlich D, Bouihat N, Poirel L, Benouda A, Nordmann P. High rate of faecal carriage of extended-spectrum β-lactamase and OXA-48 carbapenemase-producing Enterobacteriaceae at a university hospital in Morocco. Clin Microbiol Infect. 2014;20(4):350–354. doi:10.1111/1469-0691.12325
   PubMed Web of Science ®Google Scholar
• Andriatahina T, Randrianirina F, Hariniana ER, et al. High prevalence of fecal carriage of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a pediatric unit in Madagascar. BMC Infect Dis. 2010;10(1):1–8. doi:10.1186/1471-2334-10-204
   PubMed Web of Science ®Google Scholar
• Ouedraogo AS, Sanou S, Kissou A, et al. Fecal carriage of Enterobacteriaceae producing extended-spectrum beta-lactamases in hospitalized patients and healthy community volunteers in Burkina Faso. Microb Drug Resist. 2017;23(1):63–70. doi:10.1089/mdr.2015.0356
   Web of Science ®Google Scholar
• Chaudhary U, Agarwal S, Raghuraman K. Identification of extended spectrum beta lactamases, AmpC and carbapenemase production among isolates of Escherichia coli in North Indian tertiary care centre. Avicenna J Med. 2018;8(2):46–50. doi:10.4103/ajm.AJM_156_17
   Google Scholar
• Medboua-Benbalagh C, Touati A, Kermas R, et al. Fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae strains is associated with worse outcome in patients hospitalized in the pediatric oncology unit of Beni-Messous hospital in Algiers, Algeria. Microb Drug Resist. 2017;23(6):757–763. doi:10.1089/mdr.2016.0153
   PubMed Web of Science ®Google Scholar
• Babu R, Kumar A, Karim S, et al. Faecal carriage rate of extended-spectrum beta-lactamase-producing Enterobacteriaceae in hospitalised patients and healthy asymptomatic individuals coming for health check-up. J Glob Antimicrob Resist. 2016;6:150–153. doi:10.1016/j.jgar.2016.05.007
   Web of Science ®Google Scholar
• Magwenzi MT, Gudza-Mugabe M, Mujuru HA, Dangarembizi-Bwakura M, Robertson V, Aiken AM. Carriage of antibiotic-resistant Enterobacteriaceae in hospitalised children in tertiary hospitals in Harare, Zimbabwe. Antimicrob Resist Infect Control. 2017;6(10):1–7. doi:10.1186/s13756-016-0155-y
   Web of Science ®Google Scholar
• Pérez CD-A, López-Fresneña N, Carlavilla ALR, et al. Local prevalence of extended-spectrum beta-lactamase (ESBL) producing Enterobacteriaceae intestinal carriers at admission and co-expression of ESBL and OXA-48 carbapenemase in Klebsiella pneumoniae: a prevalence survey in a Spanish University Hospital. BMJ open. 2019;9(3):1–6. doi:10.1136/bmjopen-2019-030833
   Web of Science ®Google Scholar
• Ko YJ, Moon H-W, Hur M, Yun Y-M. Risk factors of fecal carriage with extended-spectrum β-lactamase-producing Enterobacteriaceae in hospitalized patients. Am J Infect Control. 2013;41(12):1241–1243. doi:10.1016/j.ajic.2013.05.018
   Web of Science ®Google Scholar
• Wilmore SS, Kranzer K, Williams A, et al. Carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae in HIV-infected children in Zimbabwe. J Med Microbiol. 2017;66(5):609–615. doi:10.1099/jmm.0.000474
   PubMed Web of Science ®Google Scholar
• Ouchar Mahamat O, Tidjani A, Lounnas M, et al. Fecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae in hospital and community settings in Chad. Antimicrob Resist Infect Control. 2019;8(1):169. doi:10.1186/s13756-019-0626-z
   Web of Science ®Google Scholar
• Ghafourian S, Sadeghifard N, Soheili S, Sekawi Z. Extended spectrum beta-lactamases: definition, classification and epidemiology. Curr Issues Mol Biol. 2015;2015(17).
   Google Scholar
• Kiremitci A, Dinleyici EC, Yargıc ZA, Durmaz G, Tekin N. Prevalence and risk factors of fecal carriage of Extended-Spectrum β-Lactamase (ESBL) -producing Enterobacteriaceae in hospitalized and ambulatory children. J Pediatr. 2011;5(2):54–58.
   Google Scholar